"It's frankly scary what people will put up with when they're losing weight" Dr Michael Crotty on the rollout of Mounjaro ...
Embarking on the quest to lose weight can be a risky business. Yo-yo dieting, compulsive binging, muscle wasting and brain ...
Ireland’s medicines watchdog has received 227 reports of suspected side effects associated with the diabetes and weight loss ...
Breeda O’Donoghue told her GP she was having no problems with the medication as the dose was increased slightly over time.
Red weather warnings issued for Scotland and Northern Ireland as Storm Eowyn battles ... identify a potential natural alternative to Ozempic 31 weird but delicious European foods, ranked ...
Professor Tim Spector has issued an urgent warning to people who may wish to take Ozempic "without a medical need". Ozempic is only indicated for the treatment of adults with insufficiently controlled ...
Ozempic alternatives offer a variety of options for those who want to switch due to side effects, availability, or cost. Below is a breakdown of readily available alternatives, all vetted by our ...
She also advised that we should treat obesity like other medical conditions. Ozempic, Wegovy and other GLP-1 drugs have been part of many discussions ever since people, including many celebrities ...
Ireland’s medicines watchdog has received 227 reports of suspected side effects associated with the diabetes and weight loss jab Ozempic in the last three years, it was confirmed yesterday.
Between 3% and 5% of colorectal cancers exhibit the KRAS G12C mutation. Credit: SewCreamStudio/Shutterstock. Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab ...
Novo Nordisk’s blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday ...
Among the drugs selected in this round are Novo Nordisk’s blockbuster weight loss medication semaglutide, sold as Ozempic and Wegovy, Pfizer’s breast cancer drug Ibrance (palbociclib), and Pfizer and ...